CoChat

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study

Itoh, Hiroshi, Komuro, Issei, Takeuchi, Masahiro, Akasaka, Takashi, Daida, Hiroyuki, Egashira, Yoshiki, Fujita, Hideo, Higaki, Jitsuo, Hirata, Ken-ichi, Ishibashi, Shun, Isshiki, Takaaki, Ito, Sadayoshi, Kashiwagi, Atsunori, Kato, Satoshi, Kitagawa, Kazuo, Kitakaze, Masafumi, Kitazono, Takanari, Kurabayashi, Masahiko, Miyauchi, Katsumi, Murakami, Tomoaki, Murohara, Toyoaki, Node, Koichi, Ogawa, Susumu, Saito, Yoshihiko, Seino, Yoshihiko, Shigeeda, Takashi, Shindo, Shunya, Sugawara, Masahiro, Sugiyama, Seigo, Terauchi, Yasuo, Tsutsui, Hiroyuki, Ueshima, Kenji, Utsunomiya, Kazunori, Yamagishi, Masakazu, Yamazaki, Tsutomu, Yo, Shoei, Yokote, Koutaro, Yoshida, Kiyoshi, Yoshimura, Michihiro, Yoshimura, Nagahisa, Nakao, Kazuwa, Nagai, Ryozo · 2018 · Diabetes Care
Cited by 69

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Diabetes is associated with high risk of cardiovascular (CV) events, particularly in patients with dyslipidemia and diabetic complications. We investigated the incidence of CV events with intensive or standard lipid-lowering therapy in patients with hypercholesterolemia, diabetic retinopathy, and no history of coronary artery disease (treat-to-target approach). RESEARCH DESIGN AND METHODS: In this multicenter, prospective, randomized, open-label, blinded end point study, eligible patients were randomly assigned (1:1) to intensive statin therapy targeting LDL cholesterol (LDL-C) <70 mg/dL (n = 2,518) or standard statin therapy targeting LDL-C 100–120 mg/dL (n = 2,524). RESULTS: Mean follow-up was 37 ± 13 months. LDL-C at 36 months was 76.5 ± 21.6 mg/dL in the intensive group and 104.1 ± 22.1 mg/dL in the standard group (P < 0.001). The primary end point events occurred in 129 intensive group patients and 153 standard group patients (hazard ratio [HR] 0.84 [95% CI 0.67–1.07]; P = 0.15). The relationship between the LDL-C difference in the two groups and the event reduction rate was consistent with primary prevention studies in patients with diabetes. Exploratory findings showed significantly fewer cerebral events in the intensive group (HR 0.52 [95% CI 0.31–0.88]; P = 0.01). Safety did not differ significantly between the two groups. CONCLUSIONS: We found no significant decrease in CV events or CV-associated deaths with intensive therapy, possibly because our between-group difference of LDL-C was lower than expected (27.7 mg/dL at 36 months of treatment). The potential benefit of achieving LDL-C <70 mg/dL in a treat-to-target strategy in high-risk patients deserves further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc17-2224

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 69

Metadata

Authors
Itoh, H., Komuro, I., Takeuchi, M., Akasaka, T., Daida, H., Egashira, Y., Fujita, H., Higaki, J., Hirata, K.-I., Ishibashi, S., Isshiki, T., Ito, S., Kashiwagi, A., Kato, S., Kitagawa, K., Kitakaze, M., Kitazono, T., Kurabayashi, M., Miyauchi, K., Murakami, T., Murohara, T., Node, K., Ogawa, S., Saito, Y., Seino, Y., Shigeeda, T., Shindo, S., Sugawara, M., Sugiyama, S., Terauchi, Y., Tsutsui, H., Ueshima, K., Utsunomiya, K., Yamagishi, M., Yamazaki, T., Yo, S., Yokote, K., Yoshida, K., Yoshimura, M., Yoshimura, N., Nakao, K., & Nagai, R.
Venue
Diabetes Care
Published
2018-04-06
Volume
41
Issue
6
Pages
1275-1284
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2795841474
Cited by
69
References
14
FWCI
7.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. https://app.cochat.ai/papers/10.2337/dc17-2224
The paper
Itoh, H., Komuro, I., Takeuchi, M., Akasaka, T., Daida, H., Egashira, Y., Fujita, H., Higaki, J., Hirata, K.-I., Ishibashi, S., Isshiki, T., Ito, S., Kashiwagi, A., Kato, S., Kitagawa, K., Kitakaze, M., Kitazono, T., Kurabayashi, M., Miyauchi, K., . . . Nagai, R. (2018). Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care. https://doi.org/10.2337/dc17-2224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.